Levocetirizine + Montelukast in pharma franchise in Manipur

Levocetirizine + Montelukast in PCD pharma franchise in Ranchi

Levocetirizine + Montelukast in top pharma company in Howrah

Levocetirizine + Montelukast in pcd pharma supplier in Ranchi

Levocetirizine + Montelukast in phama franchise company in India
Levocetirizine + Montelukast in phama distributor in Jabalpur

Home/Products /levocetirizine-5mg-montelukast-10mg-bilayered-tablet

Monclip LC Tablet

Composition : Levocetirizine (5mg) + Montelukast (10mg) Bilayered

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹139/-

Monclip LC Tablet is a combination medication designed to treat and manage symptoms associated with allergic rhinitis, seasonal allergies, and chronic urticaria, as well as to provide relief for asthma patients. It combines the benefits of two active ingredients: Levocetirizine and Montelukast, in a unique bilayered formulation for enhanced efficacy. Levocetirizine, an antihistamine, blocks histamine receptors, preventing allergic symptoms such as sneezing, itching, and watery eyes. Montelukast, a leukotriene receptor antagonist, works by inhibiting the action of leukotrienes, which contribute to airway inflammation and bronchoconstriction, making it particularly effective for asthma control.

This dual-action approach offers comprehensive management of both respiratory and allergic conditions, helping to prevent asthma attacks and reduce the frequency and severity of allergic reactions. The bilayered formulation ensures that Levocetirizine is released immediately to relieve allergy symptoms, while Montelukast is released gradually for long-lasting asthma control.

Read More

About the Product

Monclip LC Tablet is a combination medication designed to treat and manage symptoms associated with allergic rhinitis, seasonal allergies, and chronic urticaria, as well as to provide relief for asthma patients. It combines the benefits of two active ingredients: Levocetirizine and Montelukast, in a unique bilayered formulation for enhanced efficacy. Levocetirizine, an antihistamine, blocks histamine receptors, preventing allergic symptoms such as sneezing, itching, and watery eyes. Montelukast, a leukotriene receptor antagonist, works by inhibiting the action of leukotrienes, which contribute to airway inflammation and bronchoconstriction, making it particularly effective for asthma control.

This dual-action approach offers comprehensive management of both respiratory and allergic conditions, helping to prevent asthma attacks and reduce the frequency and severity of allergic reactions. The bilayered formulation ensures that Levocetirizine is released immediately to relieve allergy symptoms, while Montelukast is released gradually for long-lasting asthma control.

Common side effects include drowsiness, headache, dry mouth, dizziness, and stomach upset. Severe allergic reactions are rare.

Monclip LC Tablet is indicated for allergic rhinitis, chronic urticaria, and asthma management.

Do not use if allergic to Levocetirizine, Montelukast, or any tablet ingredients. Consult a doctor before use if pregnant, breastfeeding, or if you have liver or kidney conditions.

Store in a cool, dry place below 30°C, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation